scispace - formally typeset
Y

Yutaka Shimada

Researcher at University of Toyama

Publications -  445
Citations -  15929

Yutaka Shimada is an academic researcher from University of Toyama. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 58, co-authored 441 publications receiving 14980 citations. Previous affiliations of Yutaka Shimada include Kyoto University & Niigata University.

Papers
More filters
Journal ArticleDOI

Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

TL;DR: It is suggested that PTTG1 overexpression promotes cell motility and lymph node metastasis in ESCC patients, leading to poorer survival and global gene expression profiling suggested that several members of the Ras and Rho gene families represented potential downstream genes in the PTTGs pathway.
Journal Article

Identification of ZASC1 Encoding a Krüppel-like Zinc Finger Protein as a Novel Target for 3q26 Amplification in Esophageal Squamous Cell Carcinomas

TL;DR: The discovery of a novel member of this class, ZASC1, from a recently reported critical region of 3q26 amplification frequently observed in various squamous cell carcinomas is reported, suggesting that Zasc1 might be involved in the pathogenesis of ESC as one of the targets for 3q 26 amplification, alone or in concert with other targets.
Journal ArticleDOI

Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits.

TL;DR: The results suggest that OGT and KBG prevent the progression of atheromatous plaque by creating a sounder antioxidant defense system than vitamin E.
Journal ArticleDOI

Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis.

TL;DR: Many studies have attempted to detect cancer cells using the reverse transcription–polymerase chain reaction for specific mRNAs, but none has examined the correlation between the presence of circulating oesophageal cancer cells in peripheral blood and long‐term outcome.